Capecitabine, Oxaliplatin

DRUG4 trials

Sponsors

Royal Marsden NHS Foundation Trust, Asan Medical Center, Seoul National University Hospital, Sun Yat-sen University

Conditions

Cancer of Lymph NodeChemoradiationColorectal CancerLiver MetastasesRectal CancerRectal Cancer Stage IIRectal Cancer Stage IIIStomach Neoplasms

Phase 2

Phase II Trial Assessing Efficacy and Toxicity of Capecitabine and Oxaliplatin in the Treatment of Colorectal Cancer

CompletedNCT00220116

Royal Marsden NHS Foundation TrustColorectal Cancer

Start: 2002-08-31Updated: 2010-01-06

Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases

CompletedNCT01643070

Asan Medical CenterLiver Metastases, Rectal Cancer

Start: 2010-01-31End: 2015-12-31Updated: 2025-02-25

TNT to Increase the Clinical Complete Response Rate for Distal LARC

Active, not recruitingNCT03840239

Sun Yat-sen UniversityChemoradiation, Rectal Cancer, Rectal Cancer Stage II +1

Start: 2018-12-25End: 2027-06-30Target: 98Updated: 2023-10-25

Unknown Phase

Lymph Node Metastasis in Extended Lymphadenectomy for Gastric Cancer From a CLASSIC Trial

CompletedNCT02298010

Seoul National University HospitalCancer of Lymph Node, Stomach Neoplasms

Start: 2016-01-31End: 2017-12-31Updated: 2019-05-14

Related Papers

Safety and Efficacy of a Sandwich Total Neoadjuvant Therapy Strategy for Low‐Risk Distal Locally Advanced Rectal Cancer: Results From the TESS Phase II Trial

MedComm2026-06-17

Total neoadjuvant treatment versus standard chemoradiation to increase the sphincter preservation rate for distal locally advanced rectal cancer (TESS).

Journal of Clinical Oncology2021-05-201 citations

Preoperative intensified chemoradiotherapy with or without induction chemotherapy in patients with locally advanced rectal cancer and synchronous liver-limited resectable metastases; result from a randomized phase II study to improve both local and systemic control.

Journal of Clinical Oncology2015-05-20